Liraglutide, a once-daily human GLP-1 analogue, added to a...

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

M. Marre, J. Shaw, M. Brändle, W. M. W. Bebakar, N. A. Kamaruddin, J. Strand, M. Zdravkovic, T. D. Le Thi, S. Colagiuri, on behalf of the LEAD-1 SU study group
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Year:
2009
Language:
english
Pages:
11
DOI:
10.1111/j.1464-5491.2009.02666.x
File:
PDF, 803 KB
english, 2009
Conversion to is in progress
Conversion to is failed